NM_000176.3:c.1088A>G
Variant summary
The NM_000176.3(NR3C1):c.1088A>G (p.Asn363Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene NR3C1 is a tumor suppressor gene (CancerMine: 5 TSG, 2 oncogene, 1 driver citations). The gene NR3C1 is a known oncogene (CancerMine: 5 TSG, 2 oncogene, 1 driver citations). The gene NR3C1 is a cancer driver gene (CancerMine: 5 TSG, 2 oncogene, 1 driver citations). The variant allele was found at a cumulative frequency of 0.0271 (AC=43,688) in the gnomAD database across 1,614,126 control chromosomes, including 696 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.0331. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). The variant has been observed in cBioPortal in 1 sample across 1 study and 1 cancer type; somatic enrichment level: NONE (Observed in at most one deduplicated cBioPortal case.). This exact variant is curated in the UniProt human variants database as Uncertain Significance.
Frequency
Consequence
NM_000176.3 missense
Scores
Clinical Significance
Conservation
Publications
- glucocorticoid resistanceInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Orphanet, Ambry Genetics
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Likely_benign. The variant received -5 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| B1High frequency in general population | GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.0331 — exceeds 1% threshold (B1 applied) | ||
| B3Computational evidence does not support deleterious effect | Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3 |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000176.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
NR3C1 | MANE Select | c.1088A>G p.Asn363Ser | missense | Exon 2 of 9 | Prot: NP_000167.1 | |
NR3C1 | c.1088A>G p.Asn363Ser | missense | Exon 2 of 9 | Prot: NP_001019265.1 | ||
NR3C1 | c.1088A>G p.Asn363Ser | missense | Exon 3 of 10 | Prot: NP_001351112.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
NR3C1 | TSL:1MANE Select | c.1088A>G p.Asn363Ser | missense | Exon 2 of 9 | Prot: ENSP00000377977.2 UniProt: | |
NR3C1 | TSL:1 | c.1088A>G p.Asn363Ser | missense | Exon 2 of 9 | Prot: ENSP00000231509.3 UniProt: | |
NR3C1 | TSL:1 | c.1088A>G p.Asn363Ser | missense | Exon 3 of 10 | Prot: ENSP00000422518.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.0192 | AC:2915 | Hom:41 | AN:152158 | Cov:32 |
GnomAD2 exomes | AF: 0.0197 | AC:4944 | AN:251480 | ||
GnomAD4 exome | AF: 0.0279 | AC:40773 | Hom:655 | AN:1461850 | Cov:32 |
GnomAD4 genome | AF: 0.0191 | AC:2915 | Hom:41 | AN:152276 | Cov:32 |
TOPMed (Bravo) | AF: 0.0180 | AC:4764 | Hom:70 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0276 | AC:12412 | Hom:134 | AN:449682 | |
Local & regional cohorts 10 sources | |||||
ABraOM SABE-WGS-1171 | AF: 0.0145 | AC:34 | Hom:0 | AN:2342 | |
ChinaMAP Phase 1 | AF: 0.000197 | ||||
Denmark Genome | AF: 0.0200 | AC:6 | AN:300 | ||
ESP6500 (Exome Variant Server) | AF: 0.0220 | AC:286 | AN:13006 | ||
GenomeAsia100K | AF: 0.00433 | AC:15 | AN:3478 | ||
Qatari Genome | AF: 0.00450 | AC:9 | AN:2010 | ||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.00000800 | AC:1 | Hom:0 | AN:122640 | |
Turkish Variome | AF: 0.0119 | AC:80 | Hom:3 | AN:6722 | |
UK10K | AF: 0.0325 | AC:246 | AN:7562 | ||
WBBC (Westlake BioBank for Chinese) pilot | AF: 0.000112 | AC:1 | Hom:0 | AN:8960 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.0414 * | 460 | 11112 | 0.0397 * | 699 | 17618 |
BipEx | 0.0330 | 939 | 28420 | 0.0358 | 1034 | 28844 |
Epi25 | 0.0263 | 1104 | 41958 | 0.0255 | 1707 | 66888 |
SCHEMA | 0.0170 | 2070 | 121674 | 0.0213 | 4062 | 190982 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Uncertain | 17 | |
AlphaMissense | Benign | 0.082 | |
BayesDel_addAF | Benign | -0.67 | T |
BayesDel_noAF | Benign | -0.70 | |
CADD | Benign | 14 | |
DANN | Benign | 0.72 | |
DEOGEN2 | Benign | 0.14 | T |
Eigen | Benign | -0.66 | |
Eigen_PC | Benign | -0.46 | |
FATHMM_MKL | Benign | 0.73 | D |
FuncVEP CTI | Benign | 0.0013 | |
GPN-Star LLR | N/A | -3.6 | |
GPN-Star score | N/A | 3.6 | |
LIST_S2 | Uncertain | 0.86 | D |
MetaRNN | Benign | 0.0079 | T |
MetaSVM | Benign | -1.1 | T |
Mutation Taster | N/A | 100/0 | polymorphism (auto) |
MutationAssessor | Benign | 1.3 | L |
PhyloP100 | Benign | 0.83 | |
popEVE | Benign | -3.0 | |
PrimateAI | Uncertain | 0.58 | T |
PROVEAN | Benign | 0.090 | N |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.7 | |
REVEL | Benign | 0.052 | |
Sift | Benign | 0.69 | T |
Sift4G | Benign | 1.0 | T |
Varity_R | N/A | 0.031 | |
VESM-3B | Benign | -1.8 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.020 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.